Device type · MST
Antibodies, Gliadin
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MST
Immunology
Device class
Class II
FDA decisions since 2015
1
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Antibodies, Gliadin
- Product code
- MST
- Device class
- Class II
- Review panel
- Immunology
- Regulation
- 21 CFR 866.5750
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for MST
Latest FDA decisions
K163177 · Decided Jul 28, 2017 · 256 days after receipt
Device type: Antibodies, Gliadin (MST) · Laboratory Medicine & Pathology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2040-2023 · Started May 1, 2023 · Posted by FDA Jun 30, 2023
Reason given: Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument
Cause as FDA categorized it: Under Investigation by firm
Z-2041-2023 · Started May 1, 2023 · Posted by FDA Jun 30, 2023
Reason given: Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument
Cause as FDA categorized it: Under Investigation by firm
Z-1684-2008 · Started Mar 21, 2008 · Posted by FDA Sep 16, 2008
Reason given: Standards and controls in the Is-anti-Gliadin IgG Test Kits are exhibiting low activity. A drop in the O.D.s the Positive Control could potentially recover low out of range (which would invalidate the test), or false positive test results could be obtained.
Cause as FDA categorized it: Environmental control
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.